HK1005131A1 - Improvement of physiological tolerance of pharmaceutical active beta-amio acids - Google Patents

Improvement of physiological tolerance of pharmaceutical active beta-amio acids

Info

Publication number
HK1005131A1
HK1005131A1 HK98104267A HK98104267A HK1005131A1 HK 1005131 A1 HK1005131 A1 HK 1005131A1 HK 98104267 A HK98104267 A HK 98104267A HK 98104267 A HK98104267 A HK 98104267A HK 1005131 A1 HK1005131 A1 HK 1005131A1
Authority
HK
Hong Kong
Prior art keywords
improvement
pharmaceutical active
active beta
physiological tolerance
amio acids
Prior art date
Application number
HK98104267A
Other languages
English (en)
Inventor
Michael Matzke
Hans-Christian Militzer
Joachim Mittendorf
Franz Kunisch
Axel Schmidt
Wolfgang Schoenfeld
Karl Ziegelbauer
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of HK1005131A1 publication Critical patent/HK1005131A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/48—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyrrole Compounds (AREA)
HK98104267A 1995-07-19 1998-05-18 Improvement of physiological tolerance of pharmaceutical active beta-amio acids HK1005131A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19526274A DE19526274A1 (de) 1995-07-19 1995-07-19 Verbesserung der Verträglichkeit von pharmazeutisch wirksamen beta-Aminosäuren

Publications (1)

Publication Number Publication Date
HK1005131A1 true HK1005131A1 (en) 1998-12-24

Family

ID=7767189

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98104267A HK1005131A1 (en) 1995-07-19 1998-05-18 Improvement of physiological tolerance of pharmaceutical active beta-amio acids

Country Status (45)

Country Link
US (1) US5935988A (fr)
EP (2) EP0754678B1 (fr)
JP (2) JP3891503B2 (fr)
KR (1) KR100433968B1 (fr)
CN (1) CN1115145C (fr)
AR (1) AR003465A1 (fr)
AT (2) ATE344274T1 (fr)
AU (1) AU713555B2 (fr)
BG (1) BG62134B1 (fr)
BR (1) BR9603124A (fr)
CA (1) CA2181308A1 (fr)
CO (1) CO4700525A1 (fr)
CU (1) CU22820A3 (fr)
CZ (2) CZ287896B6 (fr)
DE (3) DE19526274A1 (fr)
DK (2) DK1043332T3 (fr)
DZ (1) DZ2073A1 (fr)
EE (1) EE03803B1 (fr)
ES (2) ES2154761T3 (fr)
GR (1) GR3035601T3 (fr)
HK (1) HK1005131A1 (fr)
HR (1) HRP960303B1 (fr)
HU (1) HUP9601977A3 (fr)
IL (1) IL118869A (fr)
MA (1) MA23940A1 (fr)
MX (1) MX9602836A (fr)
NO (1) NO315926B1 (fr)
NZ (1) NZ299008A (fr)
PE (1) PE9398A1 (fr)
PL (1) PL184861B1 (fr)
PT (2) PT1043332E (fr)
RO (1) RO118656B1 (fr)
RS (1) RS49520B (fr)
RU (1) RU2181123C2 (fr)
SA (1) SA96170491B1 (fr)
SG (1) SG47158A1 (fr)
SI (2) SI0754678T1 (fr)
SK (2) SK281850B6 (fr)
SV (1) SV1996000062A (fr)
TN (1) TNSN96100A1 (fr)
TR (1) TR199600583A2 (fr)
TW (1) TW496737B (fr)
UA (1) UA46725C2 (fr)
YU (1) YU20050685A (fr)
ZA (1) ZA966111B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191306B1 (en) * 1999-08-03 2001-02-20 Eastman Chemical Company Process for the preparation of cyclopropylglycine
KR20010073441A (ko) * 2000-01-14 2001-08-01 최인도 패류종묘 착상판의 제조방법
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US20060014697A1 (en) 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
US7169752B2 (en) 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US7105486B2 (en) * 2002-02-22 2006-09-12 New River Pharmaceuticals Inc. Abuse-resistant amphetamine compounds
US7659253B2 (en) * 2002-02-22 2010-02-09 Shire Llc Abuse-resistant amphetamine prodrugs
US7700561B2 (en) * 2002-02-22 2010-04-20 Shire Llc Abuse-resistant amphetamine prodrugs
BRPI0410792B8 (pt) * 2003-05-29 2021-05-25 New River Pharmaceuticals Inc compostos de anfetamina resistentes à dependencia

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716278D0 (en) * 1987-07-10 1987-08-19 Fujisawa Pharmaceutical Co Antimicrobial agent
JPH02174753A (ja) * 1988-08-25 1990-07-06 Fujisawa Pharmaceut Co Ltd シス―２―アミノシクロペンタンカルボン酸誘導体およびその製法ならびに抗菌剤
AU673824B2 (en) * 1992-05-29 1996-11-28 Bayer Aktiengesellschaft Cyclopentane- and -pentene-beta-amino acids
DE4302155A1 (de) * 1993-01-27 1994-07-28 Bayer Ag Verwendung von Cyclopentan- und -penten-beta-Aminosäuren
US5631291A (en) * 1992-05-29 1997-05-20 Bayer Aktiengesellschaft Cyclopentane- and -pentene-β-amino acids
GB9216441D0 (en) * 1992-08-03 1992-09-16 Ici Plc Fungicidal process
WO1995007022A1 (fr) * 1993-09-07 1995-03-16 Zeneca Limited Fongicides
DE19548825C2 (de) * 1995-12-27 1999-03-25 Rolf Dr Hermann Neue, substituierte Cyclopentylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19604225A1 (de) * 1996-02-06 1997-08-07 Bayer Ag Stoffzusammensetzungen aus alpha-Aminosäuren und Cyclohexen-beta-aminosäuren

Also Published As

Publication number Publication date
GR3035601T3 (en) 2001-06-29
EE03803B1 (et) 2002-08-15
EP0754678B1 (fr) 2001-01-03
SK281850B6 (sk) 2001-08-06
NO963000D0 (no) 1996-07-18
SI0754678T1 (en) 2001-04-30
CZ288204B6 (en) 2001-05-16
DE59611398D1 (de) 2006-12-14
ATE344274T1 (de) 2006-11-15
DK1043332T3 (da) 2007-03-12
CN1143496A (zh) 1997-02-26
PE9398A1 (es) 1998-04-15
JP2007056026A (ja) 2007-03-08
EP1043332A1 (fr) 2000-10-11
NZ299008A (en) 1998-05-27
PL184861B1 (pl) 2003-01-31
YU41796A (sh) 1999-06-15
EP0754678A2 (fr) 1997-01-22
HRP960303B1 (en) 2001-08-31
EE9600109A (et) 1997-02-17
PT754678E (pt) 2001-04-30
MX9602836A (es) 1997-01-31
HUP9601977A3 (en) 1998-04-28
HUP9601977A2 (en) 1997-05-28
TNSN96100A1 (fr) 2005-03-15
NO315926B1 (no) 2003-11-17
CZ214396A3 (en) 1997-02-12
SI1043332T1 (sl) 2007-04-30
UA46725C2 (uk) 2002-06-17
TW496737B (en) 2002-08-01
AU5948896A (en) 1997-01-23
KR970006312A (ko) 1997-02-19
EP0754678A3 (fr) 1997-12-17
JP3891503B2 (ja) 2007-03-14
DE59606266D1 (de) 2001-02-08
RU2181123C2 (ru) 2002-04-10
PT1043332E (pt) 2007-01-31
RS49520B (sr) 2006-10-27
RO118656B1 (ro) 2003-08-29
SK284733B6 (sk) 2005-10-06
MA23940A1 (fr) 1997-04-01
ZA966111B (en) 1997-02-03
KR100433968B1 (ko) 2004-08-30
ATE198469T1 (de) 2001-01-15
HU9601977D0 (en) 1996-09-30
DE19526274A1 (de) 1997-01-23
SA96170491B1 (ar) 2006-09-20
TR199600583A2 (tr) 1997-02-21
IL118869A0 (en) 1996-10-31
DK0754678T3 (da) 2001-02-05
ES2154761T3 (es) 2001-04-16
YU20050685A (sh) 2006-08-17
SK94796A3 (en) 1997-02-05
PL315330A1 (en) 1997-01-20
SG47158A1 (en) 1998-03-20
US5935988A (en) 1999-08-10
ES2275460T3 (es) 2007-06-16
BR9603124A (pt) 1998-04-22
AR003465A1 (es) 1998-08-05
DZ2073A1 (fr) 2002-07-22
JPH09202761A (ja) 1997-08-05
EP1043332B1 (fr) 2006-11-02
NO963000L (no) 1997-01-20
AU713555B2 (en) 1999-12-02
IL118869A (en) 2002-03-10
HRP960303A2 (en) 1998-02-28
CO4700525A1 (es) 1998-12-29
CZ287896B6 (cs) 2001-03-14
CA2181308A1 (fr) 1997-01-20
SV1996000062A (es) 1997-06-26
BG100716A (bg) 1997-04-30
CU22820A3 (es) 2003-01-29
CN1115145C (zh) 2003-07-23
BG62134B1 (bg) 1999-03-31

Similar Documents

Publication Publication Date Title
HUP9601698A3 (en) Pharmaceutical composition of adiabetical activity
NZ301231A (en) An optically active (+)-isomer of 2-piperidinylethoxy substituted 4-phenyl-2-benzopyran derivatives and medicaments
AU7305594A (en) Physiologically active substance-prolonged releasing-type pharmaceutical preparation
EP0859604A4 (fr) Diminution de reactions physiologiques negatives provoquees par des formulations nanoparticulaires administrees par voie intraveineuse
GB9519363D0 (en) Pharmaceutical formulation
ZA965866B (en) 6-Dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
ZA9610650B (en) 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
HK1015697A1 (en) Stable freeze-dried pharmaceutical formulation
AU4048295A (en) Peptide medicaments for the treatment of disease
EP0862431A4 (fr) Preparation pharmaceutique
HUP9900751A3 (en) Stable pharmaceutical forms of administration containing parathormone
HU9502520D0 (en) Pharmaceutical use of substituted 4-phenyl-6-amino-nicotinic acid derivatives
AU2111095A (en) Salts of omega-3-polyunsaturated fatty acids and pharmaceutical formulations containing them
HK1005131A1 (en) Improvement of physiological tolerance of pharmaceutical active beta-amio acids
HU9502426D0 (en) Compounds of pharmaceutical activity
IL124790A0 (en) Phospholipid derivatives of phosphono-carboxylic acids the production of said derivatives and the use of said derivatives as antiviral medicaments
IL115125A0 (en) Pharmaceutical formulations comprising derivatives of clavulanic acid
GB9523566D0 (en) Pharmaceutical formulation
HUP9901303A3 (en) A pharmaceutical composition for the treatment of autoimmune diseases
GB9700737D0 (en) Administration of drugs
EP0765661A3 (fr) Utilisation de l'acide docosahexaénique pour la fabrication d'un médicament pour le traitement de la glomérulonephrite
ZA968230B (en) Administration of biologically active material
AP9801196A0 (en) Pharmaceutical preparation
GB9524942D0 (en) Drug therapy
IL122872A0 (en) Quinoxaline-and quinoxalinylalkane-phosphonic acids their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20080708